tiprankstipranks
BeiGene’s Strong Market Position and Growth Potential Driven by Zanubrutinib Sales and Promising Financial Outlook
PremiumRatingsBeiGene’s Strong Market Position and Growth Potential Driven by Zanubrutinib Sales and Promising Financial Outlook
29d ago
BeiGene’s Strong Financial Performance and Promising Outlook Earns Buy Rating from Analyst
Premium
Ratings
BeiGene’s Strong Financial Performance and Promising Outlook Earns Buy Rating from Analyst
29d ago
BeiGene granted orphan designation for sonrotoclax
Premium
The Fly
BeiGene granted orphan designation for sonrotoclax
1M ago
BeiGene Faces Potential Tax Risks Amid Corporate Restructuring: Stakeholders Urged to Review SEC Filings
PremiumCompany AnnouncementsBeiGene Faces Potential Tax Risks Amid Corporate Restructuring: Stakeholders Urged to Review SEC Filings
1M ago
BeiGene Reports Strong 2024 Financial Growth and Strategic Advancements
Premium
Company Announcements
BeiGene Reports Strong 2024 Financial Growth and Strategic Advancements
1M ago
BeiGene’s Earnings Call: Strong Growth and Market Leadership
Premium
Company Announcements
BeiGene’s Earnings Call: Strong Growth and Market Leadership
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100